CLINICAL TRIALS PROFILE FOR TWINJECT 0.3

All Clinical Trials for Twinject 0.3

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02571283 ↗	Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel	Withdrawn	Arthroplasty Foundation, Inc.	Phase 4	2015-10-01	A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.
NCT02571283 ↗	Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel	Withdrawn	University of Louisville	Phase 4	2015-10-01	A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.

Clinical Trial Conditions for Twinject 0.3

Condition Name

Condition Name for Twinject 0.3
Intervention	Trials
Pain Management	1
Total Knee Arthroplasty	1

Condition MeSH

Condition MeSH for Twinject 0.3
Intervention	Trials

Clinical Trial Progress for Twinject 0.3

Clinical Trial Phase

Clinical Trial Phase for Twinject 0.3
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for Twinject 0.3
Clinical Trial Phase	Trials
Withdrawn	1

Clinical Trial Sponsors for Twinject 0.3

Sponsor Name

Sponsor Name for Twinject 0.3
Sponsor	Trials
Arthroplasty Foundation, Inc.	1
University of Louisville	1

Sponsor Type

Sponsor Type for Twinject 0.3
Sponsor	Trials
Other	2